You have read all your free articles, to continue reading subscribe to read the rest of this content.
The results of a collaboration between Oncoinvent and Sciencons researchers have been published in the Journal of Nuclear Medicine and Biology. The collaborators aim to develop a system to generate alpha-particle releasing radioimmunoconjugates that may be simpler and less time-consuming compareAlready a subscriber Login You have read all your free articles,…
ISD Immunotech has entered into a strategic research collaboration with Biogen. ISD and Biogen will work together to develop ISD's lead compound, ISD 017, which is being developed to treat severe lupus - systemic lupus erythematosus (SLE). ISD 017 is a peptide therapeutic which is an inhibitor Already a subscriber…
The companies and hospitals unite their skills and knowledge for the research of retinitis pigmentosa, a group of genetic eye disorders. The purpose of the collaboration is to examine treatments of retinitis pigmentosa by making use of IQVIA sales data and clinical data collected in the BCB retinAlready a subscriber…
Danish biotech company Acesion Pharma, which is actively developing therapeutic treatments for atrial fibrillation (AF), has raised 15.2 million DKK (2.5 million USD) in a new equity investment round. The round includes Boston-based Broadview Ventures as a new investor and current investor Novo SeedAlready a subscriber Login You have read…
